Gel Nails & Allergies: 10 Myths Busted
Acrylate allergy from nail products is on the rise — but so is the amount of misinformation circulating on social media, in training courses, and even from some product suppliers. We hear the same myths repeated so often that many technicians accept them as fact. They are not.
We reviewed 168 peer-reviewed clinical studies to put the 10 most common myths to the test. Some of what follows may surprise you.
Myth 1: "All gel polishes carry the same allergy risk"
Fact: Not all products are equal. Ingredient quality and raw material purity vary enormously between brands.
The sensitisation risk of a gel nail product depends not just on which monomers are listed on the label, but on the purity of the raw materials used to make it. Cheap or poorly purified ingredients can contain residual HEMA, acrylic acid, or methacrylic acid as contaminants — all potent sensitisers.
How bad is the problem? A 2023 Finnish study analysed 37 nail products using GC-MS (the gold standard for chemical analysis). Every single product had discrepancies between its label and actual contents. Products formulated with high-purity ingredients from reputable suppliers, manufactured under controlled conditions, present a genuinely lower sensitisation risk than those made with uncontrolled raw materials.
The cheapest products are almost always the cheapest for a reason. When a supplier cuts costs on raw material purity, they are cutting costs on your safety.
Myth 2: "HEMA-free means allergy-free"
Fact: HEMA-free products still contain other sensitising monomers — and may even contain undeclared HEMA.
Products marketed as "HEMA-free" typically replace HEMA with Di-HEMA TMHDC or other monomers. But Di-HEMA TMHDC raw material frequently contains HEMA as a manufacturing impurity, which can still trigger reactions in sensitised individuals.
Beyond that, these products still contain other known sensitisers: HPMA (661 documented cases), EGDMA (536 cases), and 2-HEA (206 cases). "HEMA-free" is not the same as "allergen-free" — it simply means one specific monomer has been substituted. The term offers reassurance, but it does not eliminate the risk.
Myth 3: "Di-HEMA TMHDC is just as dangerous as HEMA — that is why the EU restricted it"
Fact: The evidence that Di-HEMA TMHDC itself causes sensitisation is weak. The reactions are most likely driven by HEMA impurities in poor-quality raw material.
This is one of the most misunderstood issues in the nail industry. Di-HEMA TMHDC is synthesised from HEMA, and unless the raw material is highly purified, it will contain residual HEMA. The original Swedish researchers who first reported positive patch-test reactions to Di-HEMA TMHDC acknowledged in their own paper that the results could be caused by HEMA contamination in the test material.
Despite this — and despite the EU Scientific Committee on Consumer Safety (SCCS) concluding that Di-HEMA TMHDC could safely be used at concentrations up to 99% — the European Commission restricted it alongside HEMA in Regulation 2020/1682. The consequence? Brands using high-purity Di-HEMA TMHDC as a genuinely lower-risk alternative to HEMA face the same regulatory burden as products containing HEMA itself. Meanwhile, the real problem — poor raw material quality — goes unaddressed.
Myth 4: "If I am not getting a rash on my hands, I am not allergic"
Fact: The most common presentation of nail acrylate allergy is eyelid and facial dermatitis — far from the nails.
Acrylate monomers are transferred from fingertips to the face, eyelids, and neck throughout the day. Because eyelid skin is extremely thin (just 0.5 mm), it reacts first. Many clients and GPs do not connect eyelid eczema to nail products, leading to months of misdiagnosis.
Other presentations include periungual eczema (around the nail folds), fingertip pulpitis (dry, cracked fingertips), and even widespread body dermatitis. Onycholysis — the nail lifting from the nail bed — can also be a sign of acrylate allergy.
Suggest they see a dermatologist — not a GP — and specifically request patch testing with the (Meth)Acrylate Nail Series (ANS). Standard allergy tests do not include the monomers found in nail products and will almost certainly miss the diagnosis.
Myth 5: "I have been doing nails for years with no problems — I cannot suddenly become allergic"
Fact: Acrylate sensitisation is cumulative. It can develop after months or years of incident-free exposure.
Allergic contact dermatitis is a delayed-type (Type IV) hypersensitivity reaction. The immune system must first be "primed" through repeated exposures before it starts reacting. This sensitisation phase can take weeks, months, or even years.
In the clinical literature, many technicians report onset after 2–5 years of working without any protection. The fact that you have been fine until now does not mean you are immune — it means your immune system has not yet reached its threshold. Once sensitised, the allergy is permanent. There is no desensitisation treatment.
Myth 6: "My gel is HEMA-free, so my clients cannot develop an allergy"
Fact: "HEMA-free" is a marketing term, not a safety guarantee. These products still contain reactive monomers that can cause sensitisation.
"HEMA-free" means the formulation does not intentionally include HEMA as a listed ingredient. It does not mean the product is free from allergens or free from HEMA itself. Most "HEMA-free" gels replace HEMA with Di-HEMA TMHDC or other urethane methacrylates — which are still reactive monomers capable of causing sensitisation. They also typically contain crosslinkers such as HPMA, EGDMA, or TEGDMA, all of which are documented contact allergens.
A product labelled "HEMA-free" still requires the same careful handling, proper curing, and skin avoidance as any other reactive gel system.
Myth 7: "Nail allergies only affect the client, not the technician"
Fact: Nail technicians are at higher risk than clients due to daily, prolonged exposure.
Multiple studies classify nail technician dermatitis as an occupational disease. You handle uncured product all day, every day — vastly exceeding the exposure of a client who visits every few weeks. Large European multicentre studies (EECDRG, IVDK) consistently show that occupational cases in nail technicians present more severely, with widespread hand eczema that can force them out of the profession entirely.
Is that a risk worth taking for the sake of skipping gloves or ignoring proper handling procedures?
Myth 8: "If I get a reaction, I just need to switch brands"
Fact: Switching brands does not resolve the underlying sensitisation. Avoidance of all acrylates is usually necessary.
Because the core sensitising monomers (HEMA, HPMA, EGDMA, etc.) are common to virtually all UV-cured nail products, switching brands rarely solves the problem. Worse still, cross-reactivity between different (meth)acrylates is well documented — meaning sensitisation to one monomer often triggers reactions to chemically related ones.
For sensitised individuals, dermatologists typically recommend complete avoidance of all (meth)acrylate nail products. And critically, this also means being alert to acrylates in dental composites, orthopaedic bone cement, and medical adhesives later in life.
Myth 9: "My gloves protect me from acrylate exposure"
Fact: Standard disposable gloves offer only limited, short-lived protection. Latex gloves are almost useless; nitrile is better but far from permanent.
Peer-reviewed permeation studies show that HEMA breaks through latex gloves in approximately 5 minutes and through thin disposable nitrile gloves in as little as 3–5 minutes when solvents are present. Even with concentrated monomers alone, nitrile breakthrough occurs in around 15 minutes — and real-world hand movement reduces protection by a further 30% compared to laboratory testing.
Latex gloves should never be relied upon for acrylate protection. If you wear nitrile, change them every 15–20 minutes during continuous work with gel products, and immediately if product visibly contacts the glove. Double-gloving with nitrile over polyethylene can extend protection to over one hour. Never reuse disposable gloves.
Myth 10: "Any UV/LED lamp will cure my gel properly"
Fact: Using the wrong lamp can leave up to 50% of the product uncured — and uncured monomers on or near the skin are the primary driver of sensitisation.
Every gel product is formulated with specific photoinitiators that absorb light at particular wavelengths. A lamp that does not emit the right wavelengths, or does not deliver sufficient intensity, will undercure the product. The result looks firm on the surface but can leave a significant percentage of reactive monomers unpolymerised beneath.
The consequences extend well beyond the nail. During removal by filing, dust particles containing unreacted monomers become airborne and can settle on any exposed skin — often causing reactions around the eyes or on the neck. If acetone is used to soak off the gel, it dissolves and releases the unreacted monomers directly onto the surrounding skin.
Undercuring is widely considered the most common cause of acrylate allergies. Always use the lamp recommended by the product manufacturer and ensure it is in good working condition — LED bulbs degrade over time and lose output intensity. If a product feels soft, peels prematurely, or has a strong chemical smell after curing, undercuring is likely.
Quick-Fire Q&A
Can a GP diagnose nail acrylate allergy through patch testing?
Usually not. Standard patch-test series test for common allergens like nickel and fragrance, but rarely include (meth)acrylates. You need a specialist dermatologist who can test with the dedicated (Meth)Acrylate Nail Series (ANS) tray, which covers 12 nail-relevant monomers and crosslinkers.
Is LED curing safer than UV curing in terms of allergy risk?
The light source does not affect the allergy risk. Both UV and LED lamps cure the same reactive monomers. LED lamps may cure faster, potentially reducing the window of skin contact with uncured product, but the chemical risk is identical.
My client had a reaction once but wants to try again. Is that safe?
If a genuine allergic reaction has been confirmed by patch testing, re-exposure is not recommended. Acrylate sensitisation is permanent, and repeated exposure will provoke increasingly severe reactions. If the reaction was never patch-test confirmed, referral to a dermatologist is the responsible first step.
Are press-on nails a safer alternative for sensitised clients?
It depends on the adhesive. Many press-on nail adhesives contain cyanoacrylate or other (meth)acrylate monomers. A 2024 case report documented allergic contact dermatitis to isobornyl acrylate (IBOA) in a home nail glue. Sensitised individuals should check ingredients carefully or use adhesive tabs instead of liquid glue.
Questions?
If you have experienced a reaction, or if you want help understanding which products and practices will best protect you and your clients, get in touch. Our consultation is completely free of charge.
- Email: help@ikoniqnails.com
- WhatsApp: +49 160 649 7218
- Contact form: Contact Us
Based on evidence from 168 peer-reviewed studies published on PubMed (1956–2025). Key references include Suuronen K, et al., Contact Dermatitis, 2024; Voller LM & Warshaw EM, Clin Exp Dermatol, 2020; Munksgaard EC, Acta Odontol Scand, 2000; and Dahlin J, Berne B, et al., Contact Dermatitis, 2016. Full reference list available on request.
